Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Mellon Medical

Request full access

One-handed precision suturing device for safer and faster vascular surgeries

Nijmegen, NetherlandsFounded 2013Health Tech & Medtech

About Mellon Medical

Mellon Medical, established in 2013, is a Dutch medical technology company focused on advancing surgical suturing. The company was founded by vascular surgeon Mark Vrancken Peeters, who transitioned from his surgical practice to become the Chief Medical Officer of Mellon. This career change was driven by his belief that single-handed suturing could significantly improve procedural outcomes and his ambition to impact more than one patient at a time. In April 2024, Mellon Medical became part of the Demcon Group, a move intended to further support the development of its core product.

The company has developed a platform technology centered around one-handed suturing, with its leading product being the Switch®, a disposable, precision-suturing instrument. This Class III medical device operates with a simple pinch of the thumb and index finger, freeing the surgeon's other hand to present the tissue. The device uses a straight, double-pointed needle that moves between two jaws, a mechanism designed to be faster and more precise than conventional suturing, which requires passing a curved needle between instruments. The Switch® is designed to facilitate the 'small bites' suturing technique, particularly for closing the abdominal wall, which research has shown can significantly reduce postoperative complications like incisional hernias. Its pencil-like shape and balanced weight are intended to provide ergonomic use for both right- and left-handed surgeons.

Mellon Medical targets the global surgical suture and devices market, which was estimated to be worth over $3 billion. The company's business model revolves around the sale of its disposable Switch® device and accompanying suture sets. While the initial focus is on vascular surgery—specifically procedures like carotid artery surgery and kidney transplants—Mellon's technology is a platform applicable to a wide range of disciplines, including general surgery, gynecology, and urology. The company has secured approximately $7.1 million in funding through Series A and Series B rounds, with key investors including BioGeneration Ventures, Thuja Capital, and Oost NL. Mellon is collaborating with the Erasmus Medical Center for clinical validation and has partnered with Assut for the development and production of its suture sets.

Source: Dealroom company data

Mellon Medical in the Nijmegen ecosystem

Live from Dealroom

The Mellon Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

  • Thuja Capital
  • BioGeneration Ventures
  • Oost NL - Eastern Netherlands Regional Development Agency
  • David Pyott
  • BOM - Brabant Regional Development Agency

Series B and later1 investor entered at this stage

  • Demcon
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇳🇱 Netherlands100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Mellon Medical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Mellon Medical on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.